May 8 |
Biodesix GAAP EPS of -$0.14, revenue of $14.8M
|
May 8 |
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
|
May 8 |
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
|
May 7 |
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
|
Apr 24 |
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
|
Apr 13 |
The recent US$4.0m market cap decrease is likely to have disappointed insiders invested in Biodesix, Inc. (NASDAQ:BDSX)
|
Apr 9 |
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
|
Apr 5 |
Dow Jumps Over 100 Points; US Economy Adds 303,000 Jobs In March
|
Apr 5 |
Biodesix prices its 17.4M shares offering at $1.15 apiece
|
Apr 5 |
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
|